Positiveid Corp. (PSID) 0.0247 $PSID
PositiveID Successfully Detects Multiple Organisms From a Single Assay on Its Firefly Dx PCR Chip
GlobeNewswire - Thu Apr 02, 7:30AM CDT
PositiveID Corporation ("PositiveID" or "Company"
(OTCQB
SID), a developer of biological detection and diagnostics solutions, today announced that it has successfully completed additional testing of its phase II Firefly Dx prototype handheld, real-time PCR (polymerase chain reaction) pathogen detection system, and detected multiple organisms with a multiplex assay designed to simultaneously test for up to four pathogens on the Firefly Dx PCR chip.
Ticker Research Issues Company Update On PositiveID Corporation
ACCESSWIRE - Tue Mar 24, 3:30PM CDT
ROCHESTER, NY / ACCESSWIRE / March 24, 2015 / Ticker Research, a market research firm focused on the micro cap and small cap sectors, has issued a company update on Positive ID Corporation (PSID) an emerging growth company and developer of biological detection systems for America's homeland defense industry as well as rapid biological testing.
Penny Stocks Alerts for PositiveID, GT Advanced, Tanzanian Royalty Exploration, Sino Agro Food, Aoxing Pharmaceutical, and MusclePharm
PR Newswire - Mon Mar 23, 7:45AM CDT
Pennystocksinsiders.com (PSI) released FREE insider trading reports for US market investors to track the following active stocks and penny stocks: PositiveID (OTCMKTS: PSID), GT Advanced (OTCMKTS: GTATQ), Tanzanian Royalty Exploration (NYSEMKT: TRX), Sino Agro Food (OTCBB: SIAF), Aoxing Pharmaceutical (NYSEMKT: AXN), and MusclePharm (OTCMKTS: MSLP).
AXN: 1.75 (-0.05), TRX: 0.40 (+0.01)
Biotechnology And The Road To Innovation: What Companies Are Pushing New Innovation In Today's Market?
ACCESSWIRE - Thu Mar 19, 8:15AM CDT
CORAL GABLES, FL / ACCESSWIRE / March 19, 2015 / Globally, the market for biotechnology has been growing at a rate of over 10% annually according to a report from IBISWorld. Annual revenue is on the cusp of breaking $290 Billion and has many sub sectors contributing to its further expansion. Industry firms have thrived as technological advances have facilitated new discoveries and ignited higher demand from firms in the pharmaceuticals and agricultural sectors. According to the report, industry growth is forecast to continue "skyrocketing in the next five-year period" where investment in biotechnology from around the world increases, particularly from emerging economies.
PositiveID Corporation Files Additional U.S. Patent for Its Firefly Dx Real-Time PCR System
GlobeNewswire - Wed Mar 18, 7:30AM CDT
PositiveID Corporation ("PositiveID" or "Company" (OTCQB SID), a developer of biological detection and diagnostics solutions, today announced that it has filed an additional U.S. patent for its Firefly Dx real-time PCR (polymerase chain reaction) pathogen detection system titled, "A Cyclical PCR Device with Reusable Heat Zones." This brings the Company's patents and patents pending for Firefly Dx to four, and the Company's total number of patents and patents pending to 18.
PositiveID Announces First Firefly Dx Testing and Delivery of Positive PCR Results Within 20 Minutes
GlobeNewswire - Thu Mar 12, 7:30AM CDT
PositiveID Corporation ("PositiveID" or "Company" (OTCQB SID), a developer of biological detection and diagnostics solutions, today announced that it has successfully completed its first round of testing of its phase II Firefly Dx prototype handheld real-time PCR (polymerase chain reaction) pathogen detection system, and has delivered positive PCR results within 20 minutes. The Company's Firefly Dx testing was performed at standard laboratory volumes and achieved equivalent results to laboratory-based PCR instruments, which can take hours to perform the same PCR process.
PositiveID Poised To Carve Out Its Share of the $27.4 Billion Global Polymerase Chain Reaction (PCR) Market in 2015: Analyst Report Issued by Small Cap IR
PR Newswire - Thu Mar 12, 6:00AM CDT
PositiveID Corporation (OTCQB: PSID) coordinates with America's homeland defense private/public sectors to develop and produce cutting edge technologies. The Company has been working on the development of microfluidic systems with the ability to detect biological threats remotely, and analyze medical samples onsite.
Tech Takes Center Stage As New Innovation Blazes New Trails
ACCESSWIRE - Thu Feb 19, 8:20AM CST
CORAL GABLES, FL / ACCESSWIRE / February 19, 2015 / According to CEIMarket, the technology sector recorded an above average Revenue growth of 14.69 % year over year in Q4, 2014. Furthermore, sequentially revenues for Technology Sector grew by 24.57% with computer hardware, communications equipment, scientific & tech instruments, and computer services shining as sector standouts that are leading this growth. As new industries continue to develop and old markets become rejuvenated by fresh ideas, the technology space has been one to watch heading into the new year.
SeeThruEquity Issues Update Note on PositiveID Corporation
ACCESSWIRE - Tue Feb 17, 8:02AM CST
NEW YORK, NY / ACCESSWIRE / February 17, 2015 / SeeThruEquity, a leading independent equity research and corporate access firm focused on smallcap and microcap public companies, today announced that it has issued a special update note on Positive ID Corporation (OTCQB SID).
PositiveID Corporation Achieves Firefly Dx Development Milestone With Completion of Breadboard PCR
GlobeNewswire - Thu Feb 12, 7:30AM CST
PositiveID Corporation ("PositiveID" or "Company" (OTCQB SID), a developer of biological detection and diagnostics solutions, today announced that it has achieved a significant milestone in the development of its handheld Firefly Dx system with the completion of the build of its breadboard PCR (polymerase chain reaction) chip. The Company has begun testing assays to prove the design of achieving PCR results in less than 20 minutes at standard laboratory volumes, compared to existing technologies which require lab-based equipment and can take hours or days to provide results. The Company plans to announce the results of its testing as it is completed over the next several months.
PositiveID Corporation Issues Revenue Guidance of $3-6 Million for 2015
GlobeNewswire - Thu Feb 05, 7:30AM CST
PositiveID Corporation ("PositiveID" or "Company" (OTCQB SID), a developer of biological detection and diagnostics solutions, today issued revenue guidance of $3-6 million for 2015.
PositiveID Analyst Report Issued by Small Cap IR: BioThreat Detection Contender Continues Progress
PR Newswire - Thu Jan 29, 6:00AM CST
Analyst report issued by Small Cap IR. PositiveID Corp. (OTCQB: PSID) based in Delray Beach and Pleasanton, CA Fla. is a developer of biological detection and diagnostics solutions, announced today that it has completed the design of the second-phase (bench-top) prototype, the first major milestone in the development of the Firefly Dx second-phase prototype. With the completion of this design, the Company has begun to build the second-phase prototype of Firefly Dx, a real-time, handheld, polymerase chain reaction (PCR) pathogen detection system, which it expects to complete during the first half of 2015.
PositiveID Corporation to Host Shareholder Call and Webcast on January 28, 2015
GlobeNewswire - Tue Jan 27, 10:14AM CST
PositiveID Corporation ("PositiveID" or "Company" (OTCQB SID), a developer of biological detection and diagnostics solutions, announced today it will host a conference call and live webcast with presentation slides on Wednesday, January 28, 2015, at 10:30 a.m. ET, to update shareholders on the Company's business and its outlook for 2015 and beyond.
SeeThruEquity Issues Special Update on PositiveID Corp. on Second Phase Prototype of Firefly Dx
ACCESSWIRE - Tue Jan 20, 8:02AM CST
NEW YORK, NY / ACCESSWIRE / January 20, 2015 / SeeThruEquity, a leading independent equity research and corporate access firm focused on smallcap and microcap public companies, today announced that it has issued a special update on PositiveID Corp. (OTCQB: PSID) highlighting recent developments at the company including the news of completion of the design of the second phase prototype for the company's Firefly Dx product.
PositiveID Corporation Prepares Additional M-BAND Systems for Field Deployment and Testing
GlobeNewswire - Tue Jan 20, 7:30AM CST
PositiveID Corporation ("PositiveID" or "Company" (OTCQB SID), a developer of biological detection and diagnostics solutions, announced today that it is preparing additional M-BAND systems for field deployment and testing. Once deployed, the Company will have a total of six M-BAND systems in the field and under evaluation, including the four units delivered to the U.S government during the second half of 2014.
PositiveID Corporation Completes Milestone in Development of Its Firefly Dx Prototype
GlobeNewswire - Tue Jan 13, 7:56AM CST
PositiveID Corporation ("PositiveID" or "Company" (OTCQB SID), a developer of biological detection and diagnostics solutions, announced today that it has completed the design of the second-phase (bench-top) prototype, the first major milestone in the development of the Firefly Dx second-phase prototype. With the completion of this design, the Company has begun to build the second-phase prototype of Firefly Dx, a real-time, handheld, polymerase chain reaction (PCR) pathogen detection system, which it expects to complete during the first half of 2015.
PositiveID Corporation Analyst Report: Structuring a Leading Technology Issued Small Cap IR
PR Newswire - Mon Jan 12, 6:00AM CST
Analyst report issued by Small Cap IR. PositiveID Corp. (OTCBB: PSID) is an emerging growth company and developer of biological detection systems that focused on the development of microfluidic systems for the automated preparation of and performance of biological assays in order to detect biological threats at high-value locations, as well as analyze samples in a medical environment. M-BAND (Microfluidic Bio-agent Autonomous Networked Detector) and Firefly Dx are the main proprietaries of PSID.
PositiveID Corporation's Chairman and CEO Releases Letter to Stockholders
GlobeNewswire - Tue Jan 06, 7:31AM CST
PositiveID Corporation ("PositiveID" or "Company" (OTCQB SID), a developer of biological detection and diagnostics solutions, announced today that Chairman and CEO William J. Caragol released a letter to stockholders.
PositiveID Publishes Year-End Update Report on Market Opportunities for Its Bio-Threat Detection and Diagnostics Solutions
GlobeNewswire - Tue Dec 23, 7:30AM CST
PositiveID Corporation ("PositiveID" or "Company" (OTCQB SID), a developer of biological detection and diagnostics solutions, announced today it published a 2014 year-end update report on market opportunities for its homeland security and medical diagnostics technologies. A copy of the report is available on PositiveID's website at http://positiveidcorp.com/files/PositiveID_Ma...-12-19.pdf.
PositiveID Successfully Detects Multiple Organisms From a Single Assay on Its Firefly Dx PCR Chip
GlobeNewswire - Thu Apr 02, 7:30AM CDT
PositiveID Corporation ("PositiveID" or "Company"
(OTCQB SID), a developer of biological detection and diagnostics solutions, today announced that it has successfully completed additional testing of its phase II Firefly Dx prototype handheld, real-time PCR (polymerase chain reaction) pathogen detection system, and detected multiple organisms with a multiplex assay designed to simultaneously test for up to four pathogens on the Firefly Dx PCR chip. Ticker Research Issues Company Update On PositiveID Corporation
ACCESSWIRE - Tue Mar 24, 3:30PM CDT
ROCHESTER, NY / ACCESSWIRE / March 24, 2015 / Ticker Research, a market research firm focused on the micro cap and small cap sectors, has issued a company update on Positive ID Corporation (PSID) an emerging growth company and developer of biological detection systems for America's homeland defense industry as well as rapid biological testing.
Penny Stocks Alerts for PositiveID, GT Advanced, Tanzanian Royalty Exploration, Sino Agro Food, Aoxing Pharmaceutical, and MusclePharm
PR Newswire - Mon Mar 23, 7:45AM CDT
Pennystocksinsiders.com (PSI) released FREE insider trading reports for US market investors to track the following active stocks and penny stocks: PositiveID (OTCMKTS: PSID), GT Advanced (OTCMKTS: GTATQ), Tanzanian Royalty Exploration (NYSEMKT: TRX), Sino Agro Food (OTCBB: SIAF), Aoxing Pharmaceutical (NYSEMKT: AXN), and MusclePharm (OTCMKTS: MSLP).
AXN: 1.75 (-0.05), TRX: 0.40 (+0.01)
Biotechnology And The Road To Innovation: What Companies Are Pushing New Innovation In Today's Market?
ACCESSWIRE - Thu Mar 19, 8:15AM CDT
CORAL GABLES, FL / ACCESSWIRE / March 19, 2015 / Globally, the market for biotechnology has been growing at a rate of over 10% annually according to a report from IBISWorld. Annual revenue is on the cusp of breaking $290 Billion and has many sub sectors contributing to its further expansion. Industry firms have thrived as technological advances have facilitated new discoveries and ignited higher demand from firms in the pharmaceuticals and agricultural sectors. According to the report, industry growth is forecast to continue "skyrocketing in the next five-year period" where investment in biotechnology from around the world increases, particularly from emerging economies.
PositiveID Corporation Files Additional U.S. Patent for Its Firefly Dx Real-Time PCR System
GlobeNewswire - Wed Mar 18, 7:30AM CDT
PositiveID Corporation ("PositiveID" or "Company"
(OTCQB SID), a developer of biological detection and diagnostics solutions, today announced that it has filed an additional U.S. patent for its Firefly Dx real-time PCR (polymerase chain reaction) pathogen detection system titled, "A Cyclical PCR Device with Reusable Heat Zones." This brings the Company's patents and patents pending for Firefly Dx to four, and the Company's total number of patents and patents pending to 18. PositiveID Announces First Firefly Dx Testing and Delivery of Positive PCR Results Within 20 Minutes
GlobeNewswire - Thu Mar 12, 7:30AM CDT
PositiveID Corporation ("PositiveID" or "Company"
(OTCQB SID), a developer of biological detection and diagnostics solutions, today announced that it has successfully completed its first round of testing of its phase II Firefly Dx prototype handheld real-time PCR (polymerase chain reaction) pathogen detection system, and has delivered positive PCR results within 20 minutes. The Company's Firefly Dx testing was performed at standard laboratory volumes and achieved equivalent results to laboratory-based PCR instruments, which can take hours to perform the same PCR process. PositiveID Poised To Carve Out Its Share of the $27.4 Billion Global Polymerase Chain Reaction (PCR) Market in 2015: Analyst Report Issued by Small Cap IR
PR Newswire - Thu Mar 12, 6:00AM CDT
PositiveID Corporation (OTCQB: PSID) coordinates with America's homeland defense private/public sectors to develop and produce cutting edge technologies. The Company has been working on the development of microfluidic systems with the ability to detect biological threats remotely, and analyze medical samples onsite.
Tech Takes Center Stage As New Innovation Blazes New Trails
ACCESSWIRE - Thu Feb 19, 8:20AM CST
CORAL GABLES, FL / ACCESSWIRE / February 19, 2015 / According to CEIMarket, the technology sector recorded an above average Revenue growth of 14.69 % year over year in Q4, 2014. Furthermore, sequentially revenues for Technology Sector grew by 24.57% with computer hardware, communications equipment, scientific & tech instruments, and computer services shining as sector standouts that are leading this growth. As new industries continue to develop and old markets become rejuvenated by fresh ideas, the technology space has been one to watch heading into the new year.
SeeThruEquity Issues Update Note on PositiveID Corporation
ACCESSWIRE - Tue Feb 17, 8:02AM CST
NEW YORK, NY / ACCESSWIRE / February 17, 2015 / SeeThruEquity, a leading independent equity research and corporate access firm focused on smallcap and microcap public companies, today announced that it has issued a special update note on Positive ID Corporation (OTCQB
SID). PositiveID Corporation Achieves Firefly Dx Development Milestone With Completion of Breadboard PCR
GlobeNewswire - Thu Feb 12, 7:30AM CST
PositiveID Corporation ("PositiveID" or "Company"
(OTCQB SID), a developer of biological detection and diagnostics solutions, today announced that it has achieved a significant milestone in the development of its handheld Firefly Dx system with the completion of the build of its breadboard PCR (polymerase chain reaction) chip. The Company has begun testing assays to prove the design of achieving PCR results in less than 20 minutes at standard laboratory volumes, compared to existing technologies which require lab-based equipment and can take hours or days to provide results. The Company plans to announce the results of its testing as it is completed over the next several months. PositiveID Corporation Issues Revenue Guidance of $3-6 Million for 2015
GlobeNewswire - Thu Feb 05, 7:30AM CST
PositiveID Corporation ("PositiveID" or "Company"
(OTCQB SID), a developer of biological detection and diagnostics solutions, today issued revenue guidance of $3-6 million for 2015. PositiveID Analyst Report Issued by Small Cap IR: BioThreat Detection Contender Continues Progress
PR Newswire - Thu Jan 29, 6:00AM CST
Analyst report issued by Small Cap IR. PositiveID Corp. (OTCQB: PSID) based in Delray Beach and Pleasanton, CA Fla. is a developer of biological detection and diagnostics solutions, announced today that it has completed the design of the second-phase (bench-top) prototype, the first major milestone in the development of the Firefly Dx second-phase prototype. With the completion of this design, the Company has begun to build the second-phase prototype of Firefly Dx, a real-time, handheld, polymerase chain reaction (PCR) pathogen detection system, which it expects to complete during the first half of 2015.
PositiveID Corporation to Host Shareholder Call and Webcast on January 28, 2015
GlobeNewswire - Tue Jan 27, 10:14AM CST
PositiveID Corporation ("PositiveID" or "Company"
(OTCQB SID), a developer of biological detection and diagnostics solutions, announced today it will host a conference call and live webcast with presentation slides on Wednesday, January 28, 2015, at 10:30 a.m. ET, to update shareholders on the Company's business and its outlook for 2015 and beyond. SeeThruEquity Issues Special Update on PositiveID Corp. on Second Phase Prototype of Firefly Dx
ACCESSWIRE - Tue Jan 20, 8:02AM CST
NEW YORK, NY / ACCESSWIRE / January 20, 2015 / SeeThruEquity, a leading independent equity research and corporate access firm focused on smallcap and microcap public companies, today announced that it has issued a special update on PositiveID Corp. (OTCQB: PSID) highlighting recent developments at the company including the news of completion of the design of the second phase prototype for the company's Firefly Dx product.
PositiveID Corporation Prepares Additional M-BAND Systems for Field Deployment and Testing
GlobeNewswire - Tue Jan 20, 7:30AM CST
PositiveID Corporation ("PositiveID" or "Company"
(OTCQB SID), a developer of biological detection and diagnostics solutions, announced today that it is preparing additional M-BAND systems for field deployment and testing. Once deployed, the Company will have a total of six M-BAND systems in the field and under evaluation, including the four units delivered to the U.S government during the second half of 2014. PositiveID Corporation Completes Milestone in Development of Its Firefly Dx Prototype
GlobeNewswire - Tue Jan 13, 7:56AM CST
PositiveID Corporation ("PositiveID" or "Company"
(OTCQB SID), a developer of biological detection and diagnostics solutions, announced today that it has completed the design of the second-phase (bench-top) prototype, the first major milestone in the development of the Firefly Dx second-phase prototype. With the completion of this design, the Company has begun to build the second-phase prototype of Firefly Dx, a real-time, handheld, polymerase chain reaction (PCR) pathogen detection system, which it expects to complete during the first half of 2015. PositiveID Corporation Analyst Report: Structuring a Leading Technology Issued Small Cap IR
PR Newswire - Mon Jan 12, 6:00AM CST
Analyst report issued by Small Cap IR. PositiveID Corp. (OTCBB: PSID) is an emerging growth company and developer of biological detection systems that focused on the development of microfluidic systems for the automated preparation of and performance of biological assays in order to detect biological threats at high-value locations, as well as analyze samples in a medical environment. M-BAND (Microfluidic Bio-agent Autonomous Networked Detector) and Firefly Dx are the main proprietaries of PSID.
PositiveID Corporation's Chairman and CEO Releases Letter to Stockholders
GlobeNewswire - Tue Jan 06, 7:31AM CST
PositiveID Corporation ("PositiveID" or "Company"
(OTCQB SID), a developer of biological detection and diagnostics solutions, announced today that Chairman and CEO William J. Caragol released a letter to stockholders. PositiveID Publishes Year-End Update Report on Market Opportunities for Its Bio-Threat Detection and Diagnostics Solutions
GlobeNewswire - Tue Dec 23, 7:30AM CST
PositiveID Corporation ("PositiveID" or "Company"
(OTCQB SID), a developer of biological detection and diagnostics solutions, announced today it published a 2014 year-end update report on market opportunities for its homeland security and medical diagnostics technologies. A copy of the report is available on PositiveID's website at http://positiveidcorp.com/files/PositiveID_Ma...-12-19.pdf. 
